PSA Screening Significantly Lowers Prostate Cancer Death Risk, Cochrane Review Confirms
A new Cochrane review reveals that PSA blood testing reduces prostate cancer mortality by a small but significant margin. The findings, based on six m...
A new Cochrane review reveals that PSA blood testing reduces prostate cancer mortality by a small but significant margin. The findings, based on six m...
NFL tight end Greg Olsen is partnering with Novartis to promote prostate cancer screenings, urging men to overcome stigma. The campaign highlights the...
A new study reveals that the diabetes drug metformin may mimic a key effect of exercise in prostate cancer patients by increasing levels of an 'exerci...